Victory Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Buy |
47,468
+5,765
| +14% | +$164K | ﹤0.01% | 1713 |
|
|
2025
Q1 | $1.23M | Buy |
41,703
+3,395
| +9% | +$100K | ﹤0.01% | 1705 |
|
|
2024
Q4 | $1.11M | Buy |
38,308
+5,124
| +15% | +$149K | ﹤0.01% | 1758 |
|
|
2024
Q3 | $1.52M | Buy |
33,184
+11,367
| +52% | +$522K | ﹤0.01% | 1588 |
|
|
2024
Q2 | $891K | Buy |
21,817
+12,497
| +134% | +$511K | ﹤0.01% | 1760 |
|
|
2024
Q1 | $238K | Buy |
+9,320
| New | +$238K | ﹤0.01% | 2178 |
|
|
2022
Q4 | – | Sell |
-19,842
| Closed | -$324K | – | 2690 |
|
|
2022
Q3 | $324K | Buy |
19,842
+362
| +2% | +$5.91K | ﹤0.01% | 2221 |
|
|
2022
Q2 | $283K | Buy |
19,480
+387
| +2% | +$5.62K | ﹤0.01% | 2256 |
|
|
2022
Q1 | $273K | Sell |
19,093
-267
| -1% | -$3.82K | ﹤0.01% | 2326 |
|
|
2021
Q4 | $460K | Sell |
19,360
-3,153
| -14% | -$74.9K | ﹤0.01% | 2194 |
|
|
2021
Q3 | $554K | Sell |
22,513
-1,034,799
| -98% | -$25.5M | ﹤0.01% | 2122 |
|
|
2021
Q2 | $26.1M | Buy |
1,057,312
+35,256
| +3% | +$871K | 0.03% | 802 |
|
|
2021
Q1 | $22.3M | Buy |
1,022,056
+168,764
| +20% | +$3.68M | 0.02% | 870 |
|
|
2020
Q4 | $21.8M | Buy |
853,292
+49,925
| +6% | +$1.27M | 0.02% | 848 |
|
|
2020
Q3 | $22.6M | Sell |
803,367
-87,413
| -10% | -$2.46M | 0.03% | 737 |
|
|
2020
Q2 | $25.2M | Buy |
+890,780
| New | +$25.2M | 0.03% | 689 |
|